Abacavir And Lamivudine 42385-0962
Product NDC
42385-0962- Manufacturer
- Laurus Labs Limited
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- July 25, 2022
- Listing Expires
- December 31, 2027
- Application
- ANDA216332
Need to source Abacavir And Lamivudine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Abacavir Sulfate | 600 mg/1 |
| Lamivudine | 300 mg/1 |
Drug Class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]Cytochrome P450 1A1 Inhibitors [MoA]
Packaging Options(3)
180 TABLET, FILM COATED in 1 BOTTLE (42385-962-18)
30 TABLET, FILM COATED in 1 BOTTLE (42385-962-30)
90 TABLET, FILM COATED in 1 BOTTLE (42385-962-90)